Physician

Pramod Reddy Ganta, MD

According to 2025 Medicare claims, Pramod Ganta, MD (NPI: 1841236395) practices hematology/oncology in the Greenville-Anderson-Greer, SC market, with the plurality of this provider's patient population coming from Anderson, SC. This provider's primary affiliated billing organization is SIRI CANCER, BLOOD AND INFUSION CENTER (NPI: 1164897963; TIN: 475614738) and primary practice location at 29621-9998.

Ganta's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 111 traditional Medicare patients, billed 96,171 HCPCS/CPT codes, and received $1,259,313 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,025 prescription claims across 170 beneficiaries totaling $534,882 in drug costs, led by Octagam (Immun Globg(Igg)/Malt/Iga Ov50). DME data shows 13 claims. Open Payments data shows 11 records totaling $273. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $56,263 to $1,259,313. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $154,234 and ending at $534,882. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $3,581 and ending at $6,470.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	402	857	$56,263
2016	109	12,384	$176,243
2017	212	117,361	$637,961
2018	187	73,097	$595,350
2019	150	66,559	$891,537
2020	133	123,560	$1,046,966
2021	127	82,507	$1,150,820
2022	149	79,727	$1,054,630
2023	107	114,859	$1,089,614
2024	111	96,171	$1,259,313

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	157	526	$154,234
2016	66	222	$126,468
2017	127	884	$394,249
2018	119	665	$189,304
2019	100	601	$141,121
2020	105	850	$48,784
2021	112	1,464	$209,880
2022	128	1,470	$198,357
2023	135	1,575	$201,480
2024	170	3,025	$534,882

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	93	$31,226
2016	N/R	N/R	N/R
2017	N/R	160	$2,743
2018	N/R	103	$2,879
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	32	$4,557
2024	N/R	13	$4,974

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	83	510	$94
99490	Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month	96	463	$46
96372	Injection of drug or substance under skin or into muscle	101	1,909	$10
96361	Infusion into a vein for hydration, each additional hour	78	5,060	$9
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	99	1,684	$1

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Octagam	Immun Globg(Igg)/Malt/Iga Ov50	25	658	$199,897
Gammagard Liquid	Immun Glob G(Igg)/Gly/Iga Ov50	26	728	$81,319
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	26	840	$18,691
Ozempic	Semaglutide	11	504	$17,634
Januvia	Sitagliptin Phosphate	18	780	$13,661

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	13	$4,974

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	11	$273	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Pramod Reddy Ganta, MD?

Tedicare shows public-source Medicare data for Pramod Reddy Ganta, MD (NPI 1841236395), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Pramod Reddy Ganta, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Pramod Reddy Ganta, MD?

Pramod Reddy Ganta, MD is linked to SIRI CANCER, BLOOD AND INFUSION CENTER (billing NPI 1164897963) in the available physician profile data.

Does Pramod Reddy Ganta, MD have Open Payments data?

Pramod Reddy Ganta, MD has 11 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.